A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

NCT00271401 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2399

Enrollment

INDUSTRY

Sponsor class

Conditions

Angioplasty, Transluminal, Percutaneous Coronary

Interventions

OTHER: Angioplasty
OTHER: Intracoronary Stent
DRUG: Abxicimab
DRUG: Heparin
DRUG: Placebo

Sponsor

Centocor, Inc.